Careers  |  Sign In  |  Register  |   Twitter

Latest in Arthritis

FDA announces boxed warning

Risk of Infections with Etanercept

The FDA has announced a boxed warning has been added to the label for etanercept (Enbrel), for rheumatoid arthritis, to strengthen awareness of the risk of infections and particularly TB. References and Resources FDA Sponsored by The Doctor's...
Effective rheumatoid arthritis treatment may reduce the risk of heart attacks, strokes, and cardiovascular disease, according to an international study. References and Resources Naranjo A, Sokka T, Descalzo M et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the...
This research study identifies a polymorphism in the TRAF1/C5 region increases the susceptibility to and severity of RA, possibly by influencing the structure, function, and/or expression levels of TRAF1 and/or C5. References and Resources A Candidate Gene Approach Identifies the TRAF1/C5 Region as a...